M-402 Free Acid Uses, Dosage, Side Effects and more
M-402 Free Acid is under investigation in clinical trial NCT01621243 (M402 in Combination With Nab-paclitaxel and Gemcitabine in Pancreatic Cancer).
Trade Name | M-402 Free Acid |
Generic | Necuparanib |
Necuparanib Other Names | M-402 free acid, Necuparanib |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |